Stock Market Cafe
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Stock Market Cafe
No Result
View All Result
Home Trading News

European markets retreat as omicron Covid variant fears return; Stoxx 600 down 1.2%

by
December 2, 2021
in Trading News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Tesla Stock Is Dropping Again. Third-Quarter Deliveries Aren’t Its Biggest Problem.

Market Update: CBRL, EIX, ZBH

LONDON — European stocks pulled back on Thursday as concerns persisted over the omicron Covid variant.

The pan-European Stoxx 600 fell 1.2% in early trade, with tech stocks shedding 2.6% to lead losses as all sectors and major bourses slid well into the red.

Major markets across Asia-Pacific and the U.S. had bounced back Wednesday despite fears about the new variant and the Federal Reserve mulling a quicker-than-planned taper.

But global stocks appear to be struggling to regain momentum amid continuing uncertainty around the risks posed by the new omicron Covid variant, first spotted in South Africa last week and designated a “variant of concern” by the World Health Organization.

The WHO said on Wednesday that at least 23 countries from five of six WHO regions have now reported cases of omicron, “and we expect that number to grow.” It also noted that hospitalizations are rising across South Africa, but said it’s still too early to know whether the omicron variant is driving an increase in severe Covid-19 cases.

Asia-Pacific markets were mixed Thursday while U.S. stock index futures pointed to a higher open, after selling off on Wednesday as the CDC confirmed the first known case of the omicron variant in the U.S.. The first case of the heavily mutated variant was detected in northern California.

Data releases on Thursday include the euro zone unemployment rate for October and producer prices for the same month.

At the top of the Stoxx 600, Vifor Pharma shares surged more than 12% in early deals on reports that Australian biotech giant CSL is in talks to buy the Swiss group for around $10 billion.

At the bottom of the European blue chip index, Britain’s Royal Mail fell more than 6%.

Enjoyed this article?
For exclusive stock picks, investment ideas and CNBC global livestream
Sign up for CNBC Pro
Start your free trial now

ShareTweetPin

Related Posts

Tesla Stock Is Dropping Again. Third-Quarter Deliveries Aren’t Its Biggest Problem.

by
September 27, 2023
0

Market Update: CBRL, EIX, ZBH

by
September 27, 2023
0

A Few Comments on the Likely Government Shutdown

by
September 27, 2023
0

Inflation Adjusted House Prices 3.4% Below Peak; Price-to-rent index is 7.4% below recent peak

by
September 27, 2023
0

Forget About ‘Timing the Market’: Schwab Research Reveals the Optimal Way to Invest

by
September 27, 2023
0

Next Post

U.S. tightens travel testing requirements, mask mandates as part of broader plan to fight Covid

Biden asks businesses to proceed with vaccine mandate after omicron variant arrives in U.S.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Crocs sees fourth-quarter sales up 42%, CEO Andrew Rees says 2021 was ‘exceptional year’

    0 shares
    Share 0 Tweet 0
  • Biden didn’t accept Putin’s ‘red lines’ on Ukraine – here’s what that means

    0 shares
    Share 0 Tweet 0
  • Ford partners with GlobalFoundries to increase chip supplies

    0 shares
    Share 0 Tweet 0
  • CEOs across the market, economy agree on one big 2022 prediction: More volatility

    0 shares
    Share 0 Tweet 0
  • Inflation is sticking around – and Biden will likely have to wait it out like the rest of us

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.stockmarket-cafe.com
No Result
View All Result
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.stockmarket-cafe.com